Abstract
Mediastinal paragangliomas (PGLs) are extremely rare neuroendocrine tumors. Clinical presentation varies and tumor resection can be challenging due to bleeding and risk of catecholamine surges in functional tumors. We report on a case 68 with a DOTATATE avid mediastinal mass which was histopathologically confirmed as a PGL that was fed by the coronary artery in whole-body positron emission tomography/computed tomography imaging using gallium-68-DOTATATE.
Keywords:
Paraganglioma, neuroendocrine tumor, 68Ga-DOTATATE, 177Lu-DOTATATE, PET/CT
Ethics
Informed Consent: The written informed consent was obtained from the patient.
Authorship Contributions
Concept: B.O., Design: B.O., Data Collection or Processing: R.Y., M.Ö., Analysis or Interpretation: R.Y., M.Ö., Literature Search: B.O., R.Y., Writing: B.O.
Conflict of Interest: The authors declare no conflicts of interest.
Financial Disclosure: The authors declare that this study has received no financial support.
References
1
Haug AR, Cindea-Drimus R, Auernhammer CJ, Reincke M, Wängler B, Uebleis C, Schmidt GP, Göke B, Bartenstein P, Hacker M. The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors. J Nucl Med. 2012;53:1686-1692.
2
Hofman MS, Kong G, Neels OC, Eu P, Hong E, Hicks RJ. High management impact of 68Ga-DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours. J Med Imaging Radiat Oncol. 2012;56:40-47.
3
van Essen M, Krenning EP, Kam BL, de Jong M, Valkema R, Kwekkeboom DJ. Peptide-receptor radionuclide therapy for endocrine tumors. Nat Rev Endocrinol. 2009;5:382-393.
4
Chang CA, Pattison DA, Tothill RW, Kong G, Akhurst TJ, Hicks RJ, Hofman MS. 68Ga-DOTATATE and 18F-FDG PET/CT in paraganglioma and pheochromocytoma: utility, patterns and heterogeneity. Cancer Imaging. 2016;16:22.
5
Şahin R, Baloğlu MC, Ergül N, Çermik TF, Arslan E. 68Ga-DOTA-FAPI-46 PET/CT imaging for restaging in a patient with metastatic pheochromocytoma: comparison with 68Ga-DOTA-TATE PET/CT. Clin Nucl Med. 2024;49:e622-e624.
6
Satapathy S, Mittal BR, Bhansali A. Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: a systematic review and meta-analysis. Clin Endocrinol (Oxf). 2019;91:718-727.
7
Jaiswal SK, Sarathi V, Memon SS, Garg R, Malhotra G, Verma P, Shah R, Sehemby MK, Patil VA, Jadhav S, Lila AR, Shah NS, Bandgar TR. 177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma. Endocr Connect. 2020;9:864-873.
